About the AMR local indicators

Data have been uploaded across six domains: The AMR local indicators are produced by the UKHSA.

  • Supporting NHS England Initiatives
  • Antimicrobial Resistance (AMR)
  • Antibiotic Prescribing
  • Healthcare-Associated Infections (HCAI)
  • Infection Prevention and Control (IPC)
  • Antimicrobial stewardship (AMS)

Antibiotic prescribing and antibiotic resistance are inextricably linked, as overuse and incorrect use of antibiotics are major drivers of resistance. AMR local indicators are publically available data intended to raise awareness of antibiotic prescribing, AMR, HCAI, IPC and AMS; and to facilitate the development of local action plans. The data published in this tool may be used by healthcare staff, commissioners, directors of public health, academics and the public to compare the situation in their local area to the national picture.

For further information about this profile, please click here to download the user guide.

Updated indicators

March 2024 - The following indicators have been updated in the Profile AMR Local Indicators within specific topic (s) and area (s) -

Topic: Antimicrobial Resistance Area: ICB sub-locations level covering period from Q2 2021 - Q4 2023

1.    E. coli, blood, testing, carbapenem, quarterly, percentage

2.    E. coli, blood, testing, 3rd generation cephalosporin, quarterly, percentage

3.    E. coli, blood, testing, Ciprofloxacin, quarterly, percentage

4.    E. coli, blood, testing, Gentamicin, quarterly, percentage

5.    E. coli, blood, testing, piperacillin/tazobactam, quarterly, percentage

6.    E. coli, urine, testing, trimethoprim, quarterly, percentage, community

7.    E. coli, urine, resistance, trimethoprim, quarterly, percentage, community

8.    E. coli, urine, testing, nitrofurantoin, quarterly, percentage, community

9.    E. coli, urine, resistance, nitrofurantoin, quarterly, percentage, community

10. E.coli, blood, resistance, 1 Antibiotics, rolling quarterly, percentage 

11. E.coli, blood, resistance, 3 or more antibiotics classes, rolling quarterly, percentage

12.   E.coli, blood, resistance, 3rd generation cephalosporin, rolling quarterly, percentage

Topic: Antimicrobial Resistance Area: Acute Trusts covering period from Q2 2021 - Q4 2023

1.    E. coli, blood, testing, Gentamicin, quarterly, percentage

2.    E. coli, blood, testing, carbapenem, quarterly, percentage

3.    E. coli, blood, testing, Ciprofloxacin, quarterly, percentage

4.    E. coli, blood, testing, piperacillin/tazobactam, quarterly, percentage

5.    E. coli, blood, testing, 3rd generation cephalosporin, quarterly, percentage

6.    E.coli, blood, resistance, Ciprofloxacin, rolling quarterly, percentage

7.    E.coli, blood, resistance, 3rd generation cephalosporin, rolling quarterly, percentage

8.    E.coli, blood, resistance, piperacillin/tazobactam, rolling quarterly, percentage

9.    E. coli, blood, resistance, Gentamicin, quarterly, percentage

 

February 2024 - The following indicators have been updated in the Profile AMR Local Indicators within specific topic (s) and area (s) -

Topic: Healthcare Associated Infections Area: Acute Trusts, CCGs (from April 2021) up to December 2023

These indicators have been updated: 91933 92039 92040 92041 92081 92178 92193 93004 93005 93006 93007 93054 93055 93056 93057 93058 93059 93060 93061 93062 93063 93064 93065 93066 93067 93068 93069 93070 93071 93072 93073 93358 93361 93364 93365 93368 93369 93373 93374 93405 93410 93415 93420 93427

Topic: Supporting NHS England Initiative Area: Acute Trusts 

AMR CQUIN

  1. CQUIN 2023/24 Q3: Percentage of patients still receiving intravenous (IV) antibiotics past the point at which they meet IV-oral switch criteria

 

January 2024 - The following indicators have been updated in the Profile AMR Local Indicators within specific topic (s) and area (s) -

Topic: Antibiotic Prescribing Area: ICB sub-locations up to Q3 2023 (cy)

  1. Total number of prescribed antibiotic items per STAR-PU by quarter
  2. Total number of prescribed antibiotics items per 1000 resident individuals by quarter
  3. Percentage of broad - spectrum prescribed antibiotics items (cephalosporin, quinolone and co- amoxiclav class) by quarter
  4. Twelve-month rolling proportion of trimethoprim class prescribed antibiotic items as a ratio of trimethoprim to nitrofurantoin
  5. Twelve-month rolling total number of prescribed antibiotic items per 1000 resident individuals per day
  6. Twelve-month rolling total number of prescribed antibiotic items per STAR-PU
  7. Twelve-month rolling percentage of prescribed antibiotic items from cephalosporin, quinolone and co-amoxiclav class

Topic: Antibiotic Prescribing  Area: GP up to Q3 2023 (cy)

  1. Percentage of broad-spectrum prescribed antibiotic items (cephalosporin, quinolone and co-amoxiclav class) by quarter
  2. Total number of prescribed antibiotic items per 1000 registered patients by quarter
  3. Total number of prescribed antibiotic items per STAR-PU by quarter
  4. Twelve-month rolling proportion of trimethoprim class prescribed antibiotic items as a ratio of trimethoprim to nitrofurantoin

“ The method of consultations in the community during the COVID-19 pandemic (from 2020) is likely to be different from the pre-pandemic period. Therefore, comparisons of the data before and during the pandemic should be treated with caution.  Also please note that total antibacterial items have reduced over the COVID-19 period and will have had subsequent impacts on antibiotic proportions, where total antibacterial items has been used as the denominator.”

Topic: Healthcare Associated Infections Area: Acute Trusts, CCGs (from April 2021) upto November 2023

These indicators have been updated: 91933 92039 92040 92041 92081 92178 92193 93004 93005 93006 93007 93054 93055 93056 93057 93058 93059 93060 93061 93062 93063 93064 93065 93066 93067 93068 93069 93070 93071 93072 93073 93358 93361 93364 93365 93368 93369 93373 93374 93405 93410 93415 93420 93427

Topic: Antibiotic Prescribing  Area: Acute Trusts upto Q3 2023 (fy)

  1. Total antibiotic prescribing DDDs per 1000 admissions; by quarter and trust

AWaRe and broad-spectrum prescribing

  1. Carbapenem prescribing DDDs per 1000 admissions; by quarter and acute trust
  2. Proportion of total antibiotic prescribing from the "Access" category of the nationally adapted WHO AWaRe index; by quarter and acute trust
  3. Proportion of total antibiotic prescribing from the "Reserve" category of the nationally adapted WHO AWaRe index
  4. Proportion of total antibiotic prescribing from the "Watch" category of the nationally adapted WHO AWaRe index
  5. Proportion of total antibiotic prescribing from the "Watch" and "Reserve" categories of the nationally adapted WHO AWaRe index
  6. Antibiotic prescribing from the “Watch” and “Reserve” categories of the nationally adapted WHO AWaRE index; DDDs per 1000 admissions by quarter and trust

Supporting IVOS CQUIN

  1. Intravenous antibiotic prescribing; DDDs per 1000 admissions by month and NHS Acute Trust
  2. Proportion of total antibiotic prescribing administered intravenously; by month and NHS Acute Trust

 

December 2023 - The following indicators have been updated in the Profile AMR Local Indicators within specific topic (s) and area (s) -

Topic: Antibiotic Prescribing  Area: All Trust from Q4 2016/17 to Q1 2023 

  1. Antibiotic prescribing from the “Watch” and “Reserve” categories of the nationally adapted WHO AWaRE index; DDDs per 1000 admissions by quarter and trust

Updates made to data from 2016/17 Q4 to 2021/22 Q1 to amend the England trendline.

Topic: Healthcare Associated Infections Area: Acute Trusts, CCGs (from April 2021) upto October 2023

These indicators have been updated: 91933 92039 92040 92041 92081 92178 92193 93004 93005 93006 93007 93054 93055 93056 93057 93058 93059 93060 93061 93062 93063 93064 93065 93066 93067 93068 93069 93070 93071 93072 93073 93358 93361 93364 93365 93368 93369 93373 93374 93405 93410 93415 93420 93427

Topic: Healthcare-Associated Infections (HCAI) Infection Prevention and Control (IPC) Area: All Trust

  1. Surgical Site Infection Hip Prosthesis by acute NHS trust and financial year 2022/23 Crude rate – per 100 procedures
  2. Surgical Site Infection Knee Prosthesis by acute NHS trust and financial year 2022/23 Crude rate – per 100 procedures

Topic: Antimicrobial Resistance Area: ICB sub-locations level covering period from Q2 2021 - Q3 2023

1.    E. coli, blood, testing, carbapenem, quarterly, percentage

2.    E. coli, blood, testing, 3rd generation cephalosporin, quarterly, percentage

3.    E. coli, blood, testing, Ciprofloxacin, quarterly, percentage

4.    E. coli, blood, testing, Gentamicin, quarterly, percentage

5.    E. coli, blood, testing, piperacillin/tazobactam, quarterly, percentage

6.    E. coli, urine, testing, trimethoprim, quarterly, percentage, community

7.    E. coli, urine, resistance, trimethoprim, quarterly, percentage, community

8.    E. coli, urine, testing, nitrofurantoin, quarterly, percentage, community

9.    E. coli, urine, resistance, nitrofurantoin, quarterly, percentage, community

10. E.coli, blood, resistance, 1 Antibiotics, rolling quarterly, percentage 

11. E.coli, blood, resistance, 3 or more antibiotics classes, rolling quarterly, percentage

12.   E.coli, blood, resistance, 3rd generation cephalosporin, rolling quarterly, percentage

13.    E.coli, blood, resistance, Ciprofloxacin, rolling quarterly, percentage

14.    E.coli, blood, resistance, Gentamicin, rolling quarterly, percentage

15.    E.coli, blood, resistance, piperacillin/tazobactam, rolling quarterly, percentage

Topic: Antimicrobial Resistance Area: Acute Trusts covering period from Q2 2021 - Q3 2023

1.    E. coli, blood, testing, Gentamicin, quarterly, percentage

2.    E. coli, blood, testing, carbapenem, quarterly, percentage

3.    E. coli, blood, testing, Ciprofloxacin, quarterly, percentage

4.    E. coli, blood, testing, piperacillin/tazobactam, quarterly, percentage

5.    E. coli, blood, testing, 3rd generation cephalosporin, quarterly, percentage

6.    E.coli, blood, resistance, Ciprofloxacin, rolling quarterly, percentage

7.    E.coli, blood, resistance, 3rd generation cephalosporin, rolling quarterly, percentage

8.    E.coli, blood, resistance, piperacillin/tazobactam, rolling quarterly, percentage

9.    E. coli, blood, resistance, Gentamicin, quarterly, percentage

 

November 2023 - The following indicators have been updated in the Profile AMR Local Indicators within specific topic (s) and area (s) -

Topic: Antibiotic Prescribing  Area: Acute Trusts upto Q2 2023 (FY)

  1. Percentage of patients still receiving intravenous (IV) antibiotics past the point at which they meet IV-oral switch criteria (Persons) (16+ yrs) 

Topic: Healthcare Associated Infections Area: Acute Trusts, CCGs (from April 2021) upto September 2023

These indicators have been updated: 91933 92039 92040 92041 92081 92178 92193 93004 93005 93006 93007 93054 93055 93056 93057 93058 93059 93060 93061 93062 93063 93064 93065 93066 93067 93068 93069 93070 93071 93072 93073 93358 93361 93364 93365 93368 93369 93373 93374 93405 93410 93415 93420 93427

Interventions to reduce AMR

There are a number of actions that can be taken to reduce the burden of AMR. These include improved antibiotic prescribing as well as enhanced infection prevention and control, both for healthcare-associated and community-onset infections. The AMR resource handbook identifies current national policy, guidance and supporting materials in relation to antimicrobial stewardship and the infection prevention and control of healthcare associated infections in order to aid the reduction of antimicrobial resistance. 

Archived Indicators 

Archived Indicators